EUVIMEDEUVIMED entdecken
Crossref

Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19

David M Smadja, Sven Günther, Jeanne Rancic, Alexandre G Lellouch, Bertrand Renaud, Jean-Luc Diehl, Aurélien Philippe

Annales Pharmaceutiques Françaises · 2026

DOI: 10.1016/j.pharma.2026.02.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026. Verfasst von David M Smadja und 6 weiteren Autor:innen. Beteiligte Einrichtung: PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, F…. Hauptthemen laut MEDLINE: Interleukin-1 Receptor-Like 1 Protein, COVID-19, Endothelium, Vascular. Die Arbeit nennt 29 Literaturangaben. Gefördert von: AP-HP, Fondation de France, ANR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Soluble ST2 (sST2), the circulating decoy receptor of interleukin-33 (IL-33), has been validated as a prognostic biomarker of disease severity and vascular injury during acute COVID-19. However, its relevance in the context of post-acute sequelae of SARS-CoV-2 infection (PASC or long COVID) remains unclear. METHODS: We analyzed the association between plasma sST2 concentrations and clinical or vascular features in a prospective cohort of 137 long COVID patients (median age: 55 years; 49.6% male), encompassing 194 follow-up visits conducted 3 to 24 months after infection. Fatigue and dyspnea were systematically assessed, alongside full pulmonary function testing (PFTs), including diffusing capacity of the lung for carbon monoxide (DLCO). Plasma concentrations of sST2, VEGF-A, von Willebrand factor antigen (VWF: Ag) and circulating endothelial cells (CECs) were measured. RESULTS: sST2 concentrations were significantly elevated in hospitalized patients during the acute phase of COVID-19 compared to healthy controls (P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-1 Receptor-Like 1 ProteinCOVID-19Endothelium, VascularHumansPost-Acute COVID-19 SyndromeMiddle AgedMaleFemaleBiomarkersvon Willebrand FactorProspective StudiesVascular Endothelial Growth Factor AAgedRespiratory Function TestsAdultSARS-CoV-2

Stichwörter der Autor:innen

BiomarkersBiomarqueursCOVID longCOVID-19EndotheliopathyEndothéliopathieLong COVIDPASCsST2

Substanzen

Interleukin-1 Receptor-Like 1 ProteinIL1RL1 protein, humanBiomarkersvon Willebrand FactorVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France. Electronic address: david.smadja@aphp.fr.
  • PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service de Physiologie Respiratoire, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
  • PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
  • PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service d'Hématologie Biologique, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France; Division of Plastic and Reconstructive Surgery, Cedars Sinai Ho…
  • Service de Physiologie Respiratoire, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.
  • PARCC, Inserm, Université Paris-Cité, 75015 Paris, France; Service de Réanimation Médicale, Hôpital Européen Georges-Pompidou, AP-HP, 75015 Paris, France.

Förderung

  • AP-HP
  • Fondation de France
  • ANR

Zitieren

APA

Smadja, D. M., Günther, S., Rancic, J., Lellouch, A. G., Renaud, B., Diehl, J. L., & Philippe, A. (2026). Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.02.008

Vancouver

Smadja DM, Günther S, Rancic J, Lellouch AG, Renaud B, Diehl JL, et al. Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.02.008

BibTeX
@article{Smadja2026,
  author = {Smadja, David M and Günther, Sven and Rancic, Jeanne and Lellouch, Alexandre G and Renaud, Bertrand and Diehl, Jean-Luc and Philippe, Aurélien},
  title = {Soluble ST2 fails to reflect persistent endothelial dysfunction or symptoms in post-acute sequelae of COVID-19},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2026},
  doi = {10.1016/j.pharma.2026.02.008}
}
Kostenlos starten →